The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS ≤18 breast cancer.
 
Julia R. White
Research Funding - Intraop Medical (Inst)
 
Stewart J. Anderson
Consulting or Advisory Role - Jazz Pharmaceuticals
 
Eleanor Elizabeth Harris
Honoraria - Physicans' Education Resource
Research Funding - Carl Zeiss Meditec
 
Eleftherios P. Mamounas
Honoraria - Genentech/Roche; Genomic Health; Precisca
Consulting or Advisory Role - Agendia; bioTheranostics; Genomic Health; Merck; Precisca; Puma Biotechnology; Roche/Genentech
Speakers' Bureau - Genentech/Roche; Genomic Health
 
Daniel G. Stover
Consulting or Advisory Role - Novartis
 
Patricia A. Ganz
Leadership - Intrinsic LifeSciences (I)
Stock and Other Ownership Interests - Abbott Laboratories; GlaxoSmithKline; Intrinsic LifeSciences (I); Johnson & Johnson; Merck; Novartis; Pfizer; Silarus Therapeutics (I); Teva; xenon pharma (I)
Consulting or Advisory Role - Akebia Therapeutics (I); Ambys Medicines (I); American Regent (I); Astellas Pharma (I); Blue Note Therapeutics; Disc Medicine (I); GlaxoSmithKline (I); Global Blood Therapeutics (I); Gossamer Bio (I); Grail; InformedDNA; Ionis Pharmaceuticals (I); Protagonist Therapeutics (I); Regeneron (I); Rockwell Medical Technologies Inc (I); Sierra Oncology (I); Vifor Pharma (I)
Research Funding - Blue Note Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - related to iron metabolism and the anemia of chronic disease (I); Up-to-Date royalties for section editor on survivorship
Travel, Accommodations, Expenses - Intrinsic LifeSciences (I)
 
Reshma Jagsi
Employment - University of Michigan
Stock and Other Ownership Interests - Equity Quotient
Research Funding - Genentech (Inst)
Expert Testimony - Baptist Health/Dressman Benziger Lavalle Law; Kleinbard; Sherinian & Hasso Law Firm
Travel, Accommodations, Expenses - Amgen
Other Relationship - JAMA Oncology
 
Reena S. Cecchini
Consulting or Advisory Role - Allergan (I)
 
Carmen Bergom
Research Funding - Innovation Pathways
 
Valerie Theberge
No Relationships to Disclose
 
Mahmoud El-Tamer
No Relationships to Disclose
 
Richard C. Zellars
No Relationships to Disclose
 
Dean Alden Shumway
No Relationships to Disclose
 
Guang-Pei Chen
Honoraria - Accuray
 
Thomas B. Julian
No Relationships to Disclose
 
Norman Wolmark
No Relationships to Disclose